BNP and iNOS in decompensated chronic heart failure: A linear correlation

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 4, 2012, Pages 1255-1262

  Speranza, Lorenza ^a   Franceschelli, Sara ^a   Riccioni, Graziano ^b   Nicola, Marta Di ^a   Ruggeri, Benedetta ^c   Gallina, Sabina ^a,c   Felaco, Mario ^a   Grilli, Alfredo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^c Cardiology Department SS Annunziata Hospital   (Italy)

Author keywords

BNP; Decompensated Chronic Heart Failure; INOS

Indexed keywords

3 NITROTYROSINE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CITRULLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRITE;

ARTICLE; CONTROLLED STUDY; CYTOSOL; DECOMPENSATED CHRONIC HEART FAILURE; DEMOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION; WESTERN BLOTTING; AGED; CHRONIC DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; CHRONIC DISEASE; HEART FAILURE; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE SYNTHASE TYPE II;

EID: 84860852077     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e456     Document Type: Article

References (39)

1. W.F. Peacock IV, E.E. Remer, J. Aponte, D.A. Moffa, C. E. Emerman, N.M. Albert, Effective Observation Unit Treatment of Decompensated Heart Failure. Congest heart Fail 8,68-73 (2002) (Pubitemid 34303468)
2. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Strömberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, Mebazaa A, M. Nieminen, S.G. Priori, K. Swedberg ESC Committee for Practice Guidelines, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008, the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29,2388-442. (2008)
3. I. Pagel-Langenickel, J. Buttgereit, M. Bader, T.H. Langenickel, Natriuretic peptide receptor B signaling in the cardiovascular system, protection from cardiac hypertrophy. J Mol Med 85,797-810 (2007) (Pubitemid 47077112)
4. A. Kawakoshi, S. Hyodo, K. Inoue, Y. Kobayashi, and Y. Takei, Four natriuretic peptides (ANP, BNP, VNP and CNP) coexist in the sturgeo, identification of BNP in fish lineage. J Mol Endocrinol 32,47-555 (2004)
5. G.E. Woodard, J.A. Rosado, Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 268,59-93 (2008)
6. M. Yoshimura, H. Yasue, K. Okumura, H. Ogawa, M. Jougasaki, M. Mukoyama, K. Nakao, H. Imura, Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patientswith congestive heart failure. Circulation 87,464-9 (1993) (Pubitemid 23040916)
7. W. Qi, P. Mathisen, J. Kjekshus, S. Simonsen, R. Bjørnerheim, K. Endresen, C. Hall, Natriuretic peptides in patients with aortic stenosis. Am Heart J 142,725-732 (2001) (Pubitemid 32900502)
8. C. Mueller, K. Laule-Kilian, A. Scholer, B. Frana, D. Rodriguez, C. Schindler, S. Marsch, A.P. Perruchoud. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350,647-654 (2004) (Pubitemid 38364623)
9. J.L.Januzzi, R.van Kimmenade, J.Lainchbury, A.Bayes-Genis, J.Ordonez-Llanos, M.Santalo-Bel, Y.M.Pinto, M. Richards, NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure, an international pooled analysis of 1256 patients, the International Collaborative of NT-proBNP Study. Eur Heart J 27,330-7 (2006) (Pubitemid 43100029)
10. A.S. Maisel, J. McCord, R.M. Nowak, J.E. Hollander, A.H. Wu, P. Duc, T. Omland, A.B. Storrow, P. Krishnaswamy, W.T. Abraham, P. Clopton, G. Steg, M.C. Aumont, A. Westheim, C.W. Knudsen, A. Perez, R. Kamin, R. Kazanegra, H.C. Herrmann, P.A. McCullough, Breathing Not Properly Multinational Study Investigators. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41,2010-7 (2003)
11. H. Dokainish, W.A. Zoghbi, N.M. Lakkis, M.A. Quinones, S.F. Nagueh, Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93,1130-1135 (2004) (Pubitemid 38521042)
12. C.M. Yu, J.E. Sanderson, Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1, 59-65 (1999) (Pubitemid 30074676)
13. P. J. Andrew, B.Mayer, Enzymatic function of nitric oxide synthases. Cardiovas Res 43,521-531 (1999) (Pubitemid 29369251)
14. A. Grilli, M.A. De Lutiis, A. Patruno, L. Speranza, F. Gizzi, A.A. Taccardi. Inducible nitric oxide synthase and heme oxygenase-1 in rat heart, direct effect of chronic exposure to hypoxia. Ann Clin Lab Sci 33(2),208 (2003)
15. O. Gealekman, Z. Abassi, I. Rubinstein, J. Winaver, O. Binah, Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and ß-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure. Circulation 105,236-243 (2002) (Pubitemid 34084325)
16. M. Vanderheyden, J. Bartunek, M. Knaapen, M. Kockx, B. De Bruyne, M. Goethals, Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure J Heart Lung Transplant 23,723-8 (2004) (Pubitemid 38721442)
17. L. Raij, Nitric oxide in the pathogenesis of cardiac disease. J Clin Hypertens 12,30-9 (2006)
18. J.P. Ornato, R. L. Page, B. Riegel, L. F. Hiratzka, S. A. Hunt, A. K. Jacobs, R. Nishimura, J. P. Adams, J. L. Anderson, D. P. Faxon, V. Fuster, J. L. Halperin, Stevenson, C. W. Yancy, E. M. Antman, S. C. Smith, Jr, C. D. Mancini, K. Michl, J. A. Oates, P. S. Rahko, M. A. Silver, L. Warner, S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, Donna M.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation Endorsed by the Heart Rhythm Society. Circulation 112 e154-e235 (2005)
19. World Health Organization, preventing and managing the global epidemic. FIFTY-FIFTH WORLD HEALTH ASSEMBLYObesity World Health Organization Technical Report Series No. 894 Geneva (2000)
20. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart, Recommendations for chamber quantification, a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18,1440-63 (2005) (Pubitemid 41821197)
21. W.A. Zoghbi, M. Enriquez-Sarano, E. Foster., P.A Grayburn, C.D. Kraft, R.A. Levine, P. Nihoyannopoulos, C.M. Otto, M.A. Quinones, H. Rakowski, W.J. Stewart, A. Waggoner, N.J. Weissman, American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with twodimensional and Doppler echocardiography J Am Soc Echocardiogr 16,777-802 (2003) (Pubitemid 37391035)
22. H. Baumgartner, J. Hung, J. Bermejo, J.B. Chambers, A. Evangelista, B.P. Griffin, B. Iung, C.M. Otto, P.A. Pellikka, M. Quiñones, EAE/ASE. Echocardiographic assessment of valve stenosis, EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 10,1-25 (2008)
23. Authors/Task Force Members, N. Galiè, M.M. Hoeper, M. Humbert, A. Torbicki, Vachiery JL, J.A. Barbera, M. Beghetti, P. Corris, S. Gaine, J.S. Gibbs, M.A. Gomez-Sanchez, G. Jondeau, W. Klepetko, C. Opitz, A. Peacock, L. Rubin, M. Zellweger, G. Simonneau ; ESC Committee for Practice Guidelines (CPG), A. Vahanian, A. Auricchio, J.Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P. Vardas, P. Widimsky; Document Reviewers, U. Sechtem, N.Al Attar, F. Andreotti, M. Aschermann, R. Asteggiano, R. Benza, R.Berger, D. Bonnet, M. Delcroix, L. Howard, A.N. Kitsiou, I. Lang, A. Maggioni, J.E. Nielsen-Kudsk, M. Park, P. Perrone-Filardi, S. Price, M.T. Domenech, A. Vonk-Noordegraaf, J.L Zamorano. Guidelines for the diagnosis and treatment of pulmonary hypertension, The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J; 20, 2493-537 (2009)
24. A. Shubhangi, D. Nibhriti, S. Kamna, Nitric Oxide and eNOS Gene in Essential Hypertension. IJCRIMPH2. 56-71 (2009)
25. B.A. Groenning, I. Raymond, P.R. Hildebrandt, J.C. Nilsson, M. Baumann, F, Pedersen. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 90, 297-303 (2004) (Pubitemid 38250725)
26. M. Fukuchi, S.N. Hussain, A. Giaid, Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure, their relation to lesion site and beta-adrenergic receptor therapy. Circulation 98,132-9 (1998) (Pubitemid 28317893)
27. G.A. Haywood, P.S. Tsao, H.E von der Leyen, M.J. Mann, P.J. Keeling, P.T. Trindade, N.P. Lewis, C.D. Byrne, P.R. Rickenbacher, N.H. Bishopric, J.P. Cooke, W.J. McKenna, M.B. Fowler, Expression of inducible nitric oxide synthase in human heart failure. Circulation 93,1087-94 (1996) (Pubitemid 26087012)
28. R.D. Patten, D. Denofrio, M. El-Zaru, R. Kakkar, J. Saunders, F. Celestin, K.Warner, H. Rastegar, K.R. Khabbaz, J.E. Udelson, M.A. Konstam, R.H. Karas, Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart. J Am Coll Cardiol 45,1419-24 (2005) (Pubitemid 40615612)
29. H. Otani. The role of nitric oxide in myocardial repair and remodelling, Antioxid Redox Signal 11,1913-28 (2009)
30. M. Pelat, P.B. Massion, J.L. Balligand, Nitric oxide "at heart", emerging paradigms after a decade. Arch Mal Coeur Vaiss 98.242-8 (2005)
31. P. Mohan, D.L. Brutsaert, W.J. Paulus, S.U. Sys, Myocardial contractile response to nitric oxide and cGMP. Circulation 93,1223-1229 (1996) (Pubitemid 26087026)
32. R. Deardorff, F.G. Spinale, Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure. Biomark Med 3,513-523 (2009)
33. N. Li, M. Karim,is NF-kappaB the sensor of oxidative stress? FASEB J; 13,1137-1143 (1999)
34. B.H. Trachtenberg, J.M. Hare, Biomarkers of oxidative stress in heart failure. Heart Fail Clin; 5,561-77 (2009)
35. H. Tsutsui, S. Kinugawa, S. Matsushima, Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 81, 449-56 (2009)
36. R. Madonna, P. Di Napoli, M. Massaro, A. Grilli, M. Felaco, A. De Caterina, D. Tang, R. De Caterina, Y.J. Geng, Simvastatin attenuates expression of cytokineinducible nitric-oxide synthase in embryonic cardiac myoblasts. J Biol Chem 280,13503-11 (2005)
37. J.S. Beckman Tsai JHM, Reaction and diffusion of nitric oxide and peroxynitrite. Biochemist 16,8-10 (1994)
38. P. Pacher, J.S. Beckman, L.Liaudet, Nitric oxide and peroxynitrite in health and disease. Physiol Rev; 87,315-424 8 (2007) (Pubitemid 46217686)
39. R, D, Patten, D. Denofrio, M. El-Zaru, R. Kakkar, J. Saunders, F. Celestin, K. Warner, H. Rastegar, K.R. Khabbaz, J.E. Udelson, M.A. Konstam, R.H. Karas, Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart. J Am Coll Cardiol 45,1419-24 (2005) (Pubitemid 40615612)